Company / Operating Margin
Boston Scientific Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
18.0%
FY2025
5-year range
13.0% / 18.0%
FY2021-FY2025
Trend
+15.8%
vs FY2024
Sector context
#22 of 148
Health Care
What the data says
Boston Scientific's operating margin of 18.0% is higher than 85% of companies in the Health Care sector (FY2025). Operating Margin has fluctuated over the past 10 years, ranging from 4.9% in FY2016 to 18.0% in FY2025.
Based on SEC 10-K filings.
18.0% in FY2025 with a 5-year CAGR of +2.7%. Top quartile in the Health Care sector.
Improved from 16.4% to 18.0% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +5.0pp
- 5-Year Change
- +2.7pp
- 10-Year Change
- -
Sector benchmark
+106.3% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 15.8% year-over-year.
- Currently 302.8pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 18.0% | +15.8% |
| FY2024 | 15.5% | -5.5% |
| FY2023 | 16.4% | +26.5% |
| FY2022 | 13.0% | -8.1% |
| FY2021 | 14.1% | -7.8% |
| FY2020 | 15.3% | +8.4% |
| FY2019 | 14.1% | -7.8% |
| FY2018 | 15.3% | +8.0% |
| FY2017 | 14.2% | +188.0% |
| FY2016 | 4.9% | +240.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026